Dupixent

This page shows the latest Dupixent news and features for those working in and with pharma, biotech and healthcare.

Sanofi reports a profit in Q4 as Dupixent sales climb

Sanofi’s speciality care business performed particularly well, growing 18.3% thanks to the strong performance of immunology product Dupixent (dupilumab). ... For the full year, Dupixent generated sales of 3.5bn, again making gains on Sanofi’s

Latest news

FDA approves Sanofi’s key cancer drug Sarclisa for myeloma

That included its blockbuster immunology treatment Dupixent (dupilumab), its vaccine business and a robust pipeline littered with potential candidates for rare disease, multiple sclerosis and breast and lung cancer.
Incyte’s JAK inhibitor cream clears second eczema trial

So if approved, ruxolitinib cream would address a less severely-affected population than new biologic agents such as Sanofi/Regeneron’s blockbuster Dupixent (dupilumab) antibody.
Sanofi highlights MS drug data as it swings to a loss in Q4

The new MS data comes as Sanofi swung to a small, 10m net loss in the fourth quarter of 2019, despite another strong performance by immunology drug Dupixent (dupilumab) which grew ... Dupixent plus solid growth for Sanofi’s vaccines business lifted
Lilly expands dermatology portfolio with $1.1bn Dermira deal

If approved, Lilly’s newly acquired drug will closely compete with Sanofi/Regenerons’s Dupixent (dupilumab) which grew 142% in the last quarter to $637m.
Almirall eyes $62m takeover of multicytokine specialist Bioniz

If approved, that would be a rival to Sanofi and Regeneron’s fast-growing atopic dermatitis therapy Dupixent (dupilumab).

More from news
Approximately 22 fully matching, plus 30 partially matching documents found.

Latest Intelligence

20 for 2020 – Five pharma leaders to watch in 2020

Dupixent for eczema and asthma – in order to ramp up internal generation of new drug candidates.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Freelance Medical Writer - Creative Healthcare Comms - 2 month t...: Excellent Day Rate

Account Management: Competitive Salary Offered

Senior Content Editor - Biotechnology: Salary TBC

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

Freelance Account Manager - Creative Healthcare Comms - Immediat...: Excellent Day Rate

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

PMHub

Add my company

Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

How a design mindset can lead to better medical outcomes: By adopting a design philosophy, healthcare companies can develop communications that allow healthcare professionals (HCPs) to better meet the needs of their patients. Imaginatively designed content combined with patient insights...
How does the government plan to reshape the NHS?: Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care...
Want to give perfect client service? Tough luck, you’re human: In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...